Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

No evidence for an association of osteopontin plasma levels with disease activity in multiple sclerosis.
Pain and Cognition in Multiple Sclerosis.
Dramatically changing rates and reasons for hospitalization in multiple sclerosis.
Current role of chemotherapy and bone marrow transplantation in multiple sclerosis.
Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use.
New opportunities of real world data from clinical routine settings in life cycle-management of drugs: example of an integrative approach in multiple sclerosis.
The choroid plexus is modulated by various peripheral stimuli: implications to diseases of the central nervous system.
Deletion of caspase-8 in mouse myeloid cells blocks microglia pro-inflammatory activation and confers protection in MPTP neurodegeneration model.
Human endogenous retrovirus-K contributes to motor neuron disease.
EphB3 receptors function as dependence receptors to mediate oligodendrocyte cell death following contusive spinal cord injury.
Multiple sclerosis relapse phenotype is an important, neglected determinant of disease-outcome: Commentary.
Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple Sclerosis.
Accumulation of reactivity to MBP sensitizes TRAIL mediated oligodendrocyte apoptosis in adult sub cortical white matter in a model for human multiple sclerosis.
Iron Oxide as an MRI Contrast Agent for Cell Tracking.
Advances in the management of MS symptoms: recently proposed clinical management algorithms.
Recommendations for observational studies of comorbidity in multiple sclerosis.
High-Throughput Screening Platform for the Discovery of New Immunomodulator Molecules from Natural Product Extract Libraries.
A 12-month prospective, observational study evaluating the impact of disease-modifying treatment on emotional burden in recently-diagnosed multiple sclerosis patients: The POSIDONIA study.
Non pharmacological interventions for spasticity in multiple sclerosis.
Subretinal angiostrongyliasis-induced optic neuritis.
Sex-specific extent and severity of white matter damage in multiple sclerosis: Implications for cognitive decline.
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis - a systematic review.
Serum analysis by 1H Nuclear Magnetic Resonance spectroscopy: a new tool for distinguishing neuromyelitis optica from multiple sclerosis.
Efficacy and safety of natalizumab treatment for relapsing-remitting multiple sclerosis: interim results of the tysabri(r) observational programme in the uk.

Pages